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The underlying purpose of this commentary and position paper is to achieve evidence-based recommendations on
prevention of work-related musculoskeletal disorders (MSDs). Such prevention can take different forms (primary,
secondary and tertiary), occur at different levels (i.e. in a clinical setting, at the workplace, at national level) and
involve several types of activities. Members of the Scientific Committee (SC) on MSDs of the International
Commission on Occupational Health (ICOH) and other interested scientists and members of the public recently
discussed the scientific and clinical future of prevention of (work-related) MSDs during five round-table sessions at
two ICOH conferences (in Cape Town, South Africa, in 2009, and in Angers, France, in 2010). Approximately 50
researchers participated in each of the sessions. More specifically, the sessions aimed to discuss new developments
since 1996 in measures and classification systems used both in research and in practice, and agree on future needs
in the field.
The discussion focused on three questions: At what degree of severity does musculoskeletal ill health, and do
health problems related to MSDs, in an individual worker or in a group of workers justify preventive action in
occupational health? What reliable and valid instruments do we have in research to distinguish ‘normal
musculoskeletal symptoms’ from ‘serious musculoskeletal symptoms’ in workers? What measures or classification
system of musculoskeletal health will we need in the near future to address musculoskeletal health and related
work ability?
Four new, agreed-upon statements were extrapolated from the discussions: 1. Musculoskeletal discomfort that is at
risk of worsening with work activities, and that affects work ability or quality of life, needs to be identified. 2. We
need to know our options of actions before identifying workers at risk (providing evidence-based medicine and
applying the principle of best practice). 3. Classification systems and measures must include aspects such as the
severity, frequency, and intensity of pain, as well as measures of impairment of functioning, which can help in
prevention, treatment and prognosis. 4. We need to be aware of economic and/or socio-cultural consequences of
classification systems and measures.
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In 1996, the Scientific Committee (SC) on Musculoskel-
etal Disorders (MSDs) of the International Commission
on Occupational Health (ICOH) (www.icohweb.org)
published a position paper [1] on work-related risk fac-
tors and prevention of MSDs in workers. The conclusion
back then was that international organizations should
work to develop standards, common classifications, and
uniform terminologies related to MSDs. In addition, sur-
veillance systems should be further developed nationally,
based on the International Labour Organization (ILO)’s
definition of ‘surveillance’ [2] (www.ilo.org):
Workers' health surveillance is a generic term which
covers procedures and investigations to assess workers’
health in order to detect and identify any abnormality.
The results of surveillance should be used to protect and
promote the health of the individual, collective health at
the workplace, and the health of the exposed working
population. Health assessment procedures may include,
but are not limited to, medical examinations, biological
monitoring, radiological examinations, questionnaires or
a review of health records.
Since the first position paper and especially in the first
decade of this century, the literature on surveillance of
MSDs in workers presents ongoing discussions concern-
ing both the definitions and the relevance of measured
outcomes in musculoskeletal occupational medicine [3-
10]. This literature aimed to facilitate a more uniform
collection, recording and reporting of information about
(work-related) MSDs across countries by providing
evidence- or consensus-based case definitions and cri-
teria for identifying and classifying them. Noticeably,
these publications have been the result of the collabora-
tive effort of several groups of experts, and provide an
invaluable contribution to harmonize the scientific
approaches to prevention of (work-related) MSDs. In the
literature reviews of diagnostic criteria, the definitions
and official statistics were found to be rarely comparable
across countries, for several good reasons. However, the
consensus-based publications of definitions and criteria
should facilitate the practical work of those involved in
this field, as shown in later studies (see, e.g., [11-13].
Despite the impressive number of studies on (work-
related) low back and upper extremity MSDs in worker
populations, considerable uncertainty and even contro-
versy still exists about the extent and aetiology of these
problems, the contribution of work and non-work risk
factors to their development and resolution, the criteria
used to diagnose them, the outcomes of various treat-
ment methods and, of utmost importance, the appropri-
ate strategies for intervention and prevention.
One and a half decades and another several reviews
after the 1996 paper of the ICOH’s SC on MSDs, we
have to acknowledge that agreed-upon knowledge is stilllacking about meaningful case definitions and about
possible underlying mechanisms for the development of
non-specific musculoskeletal symptoms in particular and
(chronic) pain in general. It remains difficult to compare
the results of different epidemiological studies, surveil-
lance systems, and registration databases (e.g. [14]. This
difficulty hampers efforts to assess and compare the
magnitude and nature of work-related MSDs within and
across different countries, geographic areas, industries,
workplaces, and occupational groups over time. Simi-
larly, it impedes the ability to assess the effectiveness of
different types of medical and workplace interventions.
Scientific progress in advancing our understanding of
the abovementioned problems is still being hampered by
methodological and practical challenges associated with
epidemiological research on work-related MSDs (e.g.
[15].
Having said this, our scientific knowledge should be
designed to be used in practice, primarily for occupa-
tional health physicians who provide care for individual
workers with health problems and who provide occupa-
tional health services to workers and employers in differ-
ent companies. The recognition of work-related disease
and injury often begins in the physician’s office, once
patients decide to seek help for their symptoms, com-
plaints or functional limitations. Clearly, the clinical
process is dynamic and physicians use their best medical
judgment in making a diagnosis and decide on what ac-
tion is necessary. Sometimes, information about work-
related MSDs is solicited in a more active way to help
identify existing or potential problems and risks in cer-
tain occupational groups or in particular workplaces.
This type of action can be initiated by occupational
health professionals who provide prevention-oriented
services to companies and groups of workers, often at
the request of employers or workers. Health or labour
authorities may engage in or require occupational health
surveillance for high-risk groups or when alerted to pos-
sible problems through other means.
Main text
The underlying purpose of this article and position
paper is to achieve evidence-based recommendations on
prevention of work-related MSDs. Such prevention can
take different forms (primary, secondary and tertiary),
occur at different levels (i.e. in a clinical setting, at the
workplace, at national level) and involve several types of
activities.
Members of the ICOH’s SC on MSDs and other inter-
ested scientists and members of the public recently dis-
cussed the scientific and clinical future of prevention of
(work-related) MSDs during five round-table sessions at
two ICOH conferences, in Cape Town, South Africa, in
2009 and in Angers, France, in 2010. The focus of the
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taken place since 1996 with regard to the measures and
classification systems used in research and practice, and
agree on what is needed in the near future.
The discussion focused on three questions: At what
degree of severity does musculoskeletal ill health, and do
health problems related to MSDs, in an individual
worker or in a group of workers justify preventive action
in occupational health? What reliable and valid instru-
ments do we have in research to distinguish ‘normal
musculoskeletal symptoms’ from ‘serious musculoskel-
etal symptoms’ in workers? What measures or classifica-
tion system of musculoskeletal health will we need in
the near future to address musculoskeletal health and
related work ability?
Forty-five minutes were allocated to each question.
Three to four members of the SC were asked to prepare
their views in advance, to start the discussion with ex-
pert opinions from different parts of the world. Immedi-
ately following the discussions, some statements were
prepared by the organizers of the round-table discus-
sions (J.S., M.H., F.V., R.B.) and discussed in a fourth
round-table session. Four new, agreed-upon statements
were extrapolated from the discussions and are given
below.
1. Musculoskeletal discomfort that is at risk of
worsening with work activities, and that affects work
ability or quality of life, needs to be identified.
Unpleasant sensations from the musculoskeletal
system are experienced by everyone and can be
adaptive in circumstances when muscle soreness is
experienced after physical training, for example. In
prevention of work-related MSDs, we need to assess
musculoskeletal symptoms that have a potential of
affecting workers’ health in a negative way.
Symptoms at risk of worsening (e.g. paraesthesia as
a first phase before pain may be present in
entrapment syndromes) which reduce work ability
or impair quality of life should be targeted.
Questions like ‘What probabilities should be
avoided?’ are likewise relevant. The core outcome
domains recommended by the Initiative on
Methods, Measurement, and Pain Assessment in
Clinical Trials (IMMPACT) [16] for clinical trials of
chronic pain can provide some guidance. These are:
pain, physical functioning, emotional functioning,
global wellbeing, symptoms and adverse events, and
participant disposition.
Pain that is worsening with work activities should be
detected since this will probably influence
productivity in addition to affecting quality of life.
One idea that emerged involves a measure that
couples pain with a measure of functioning.Examples of reliable and valid instruments used
today to target part of these aspects are: the Work
Ability Index (WAI; www.ttl.fi) [17], the Work
Limitation Questionnaire (WLQ) [18] and the Work
Role Functioning Questionnaire (WRFQ) [19].
Furthermore, the Nordic Musculoskeletal
Questionnaire (NMQ) [20,21] and the Disabilities of
the Arm, Shoulder and Hand (DASH) questionnaire
[22] aim specifically at musculoskeletal symptoms
and functioning.
2. We need to know our options of actions before
identifying workers at risk (providing evidence-based
medicine and applying the principle of best practice).
Identifying workers at risk for developing MSDs or
worsening of MSD symptoms related to work
involves ethical issues. A management plan on how
to give feedback to the worker and management (as
well as unions and other stakeholders) should be
considered before starting any health screening or
surveillance of workers. The ICOH ethical guidelines
state that we need to know our options of actions
before identifying workers at risk. It is important to
make some judgement about which symptoms are
related to work exposures in order to predict what
will get worse with work exposures and what will
get better if work exposure is decreased.Action on
individual resources or work demands should follow
screening, using reliable and valid exposure
instruments [6]. Criteria for addressing symptoms
can be derived from knowledge of the prognosis,
and of the effect of the symptoms on productivity
and quality of life.It may be too early to recommend
specific criteria or cut-off levels to identify workers
at risk. However, examples from practices from
different countries in setting criteria at the individual
level that was asked for and mentioned in our
discussion are: using a visual analogue scale (VAS)
to assess pain and setting the criteria to 50 mm to
identify ‘severe’ complaints/disorders. In Finland a
rating of 70–100 is regarded as justifying
intervention [23]. In France, a score of ≥50 is seen
to indicate serious symptoms.
Another example of action taken is when
musculoskeletal complaints are the main health
problem in workers scoring <6 for poor work ability
on the 11-point scale of the Finnish WAI [24];
sometimes only the first item of the WAI is used and
action can be taken based on that score [25]. In the
Netherlands, an example of another type of health
complaint, fatigue, was mentioned at the group level
when the organizational or departmental criterion
for action to be taken was defined as more than half
of the workers scoring above the cut-off score on the
Need for Recovery (NFR) after work scale [26].
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aspects such as the severity, frequency, and intensity
of pain, as well as measures of impairment of
functioning, which can help in prevention, treatment
and prognosis.
To date, several classification systems for MSDs
have been proposed and published in the literature,
mainly aimed at defining diagnostic criteria. This is
probably due to the importance of diagnosis for
understanding the underlying pathological process
as a prerequisite for the management of prevention
and treatment of diseases.
Even when the pathogenesis of illnesses is unclear, a
case definition can be considered a useful way of
classifying cases so that illnesses that share the same
causes or a similar prognosis and response to
treatment can be managed or prevented more
effectively [27]. This links to the first statement
“Musculoskeletal discomfort that is at risk of
worsening with work activities, and that affects work
ability or quality of life, needs to be identified”. The
case definition for a disorder may vary according to
the purpose for which it is being applied. Even
broad, i.e. non-specific, case definitions may usefully
identify workers at risk of progressing to more
serious outcomes (see, e.g., [28].
However, it is well recognized that it may not be
sufficient to merely explore physical symptoms when
nothing is known about the impact of the symptoms
on functioning or work ability. The International
Classification of Functioning (ICF) is an example of
a classification system addressing functioning,
disability and health in individuals and groups of
individuals (www.who.int/classifications/icf/en/).
One of the challenges for the scientific community
that was agreed upon is to gain better understanding
of the effect of the different aspects of the work
environment on the functioning of the worker with
certain MSD problems. We will then be able to
propose better solutions to address these problems
in time.
4. We need to be aware of economic and/or socio-
cultural consequences of classification systems and
measures.
The scientific community should be aware of the
societal impact of communicated work-related
health problems. Legal disputes over compensation
may affect work ability [29]. In Australia repetitive
strain injuries (RSI) was debated in society during
the 1980s which may have hampered adequate
prevention at the time [30]. Reaction to
musculoskeletal trauma may be influenced also by
ethnicity [31]. We know from practised systems of
defining occupational diseases that estimates ofincidences may differ 60-fold between the different
European Union (EU) countries. The consequences
of classification systems and measures need to be
elucidated and evaluated to minimize the risk of
adverse effects on the individual worker and on
society.
Discussion
More attention in research should be directed to the
functional impact of complaints in working life and also
to solutions (interventions) to decrease this impact.
There is a need for knowledge on what screening criteria
best fit what type of interventions. Furthermore, with
non-preventable factors, such as age, or where MSDs
have are chronic, the goal is to reduce the impact of the
condition on workers’ quality of life and ability to work.
In fact, musculoskeletal function is related to physical
capacity, one of the factors affecting the balance between
work requirements and the worker’s performance cap-
acity. In other words, musculoskeletal function is one of
the determinants of work ability and may influence
workers’ quality of life, the number of working days lost,
and productivity.
As a consequence, musculoskeletal function is a par-
ameter to consider in case definitions. It can be mea-
sured through physical examination and on the basis of
specific protocols, with the aim to assess both basic
functional abilities and work-specific abilities. New
knowledge on how musculoskeletal function can be used
in case definitions is urgent.
Tools to measure individuals’ perceived ability have
also been developed in the form of self-administered
questionnaires. The scores or indexes obtained are used
to describe and monitor changes in function over time.
However, information is needed on minimal detectable
changes and minimal clinical significant changes of these
instruments.
Given these objectives, there is a need for knowledge
on how to integrate the diagnostic classification systems
of MSDs with procedures to evaluate physical function-
ing and workers’ perceived disability. This will allow a
deeper understanding of the impact of musculoskeletal
conditions on work ability and it will enable us to assess
the effectiveness of preventive strategies or interventions
aimed at reducing the burden of MSDs.
The adversarial and acrimonious climate in some coun-
tries, due, in large part, to issues surrounding compensa-
tion, have hindered the development of scientific
knowledge on the prevention of work-related MSDs.
There is therefore a need for knowledge about how the
scientific community can realistically communicate the
impact of work-related MSDs on sustainable work ability
to governmental bodies and society. Integrating health
economics into future musculoskeletal research may be an
Hagberg et al. BMC Musculoskeletal Disorders 2012, 13:109 Page 5 of 6
http://www.biomedcentral.com/1471-2474/13/1/109effective way of getting through to the public, politicians
companies and managers. We need new knowledge on
the costs of preventable musculoskeletal disorders[32]. Fi-
nally we need more information on productivity and sus-
tainable musculoskeletal health [33].
Future position papers of the ICOH’s SC on MSDs
should focus on the following topics: relevant interven-
tions when physical demands remain high; and implemen-
tation of interventions with focus on how to standardize
and implement a more individualized approach.
Conclusions
Four new, agreed-upon statements concerning preven-
tion of musculoskeletal disorders in workers were extra-
polated from the discussions with scientists in the field:
1. Musculoskeletal discomfort that is at risk of worsen-
ing with work activities, and that affects work ability or
quality of life, needs to be identified. 2. We need to
know our options of actions before identifying workers
at risk (providing evidence-based medicine and applying
the principle of best practice). 3. Classification systems
and measures must include aspects such as the severity,
frequency, and intensity of pain, as well as measures of
impairment of functioning, which can help in preven-
tion, treatment and prognosis. 4. We need to be aware
of economic and/or socio-cultural consequences of clas-
sification systems and measures.
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